Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00383773

Enrollment

Registered

2006-10-04

Start date

2006-10-31

Completion date

2007-10-31

Last updated

2006-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Retinal Vein Occlusion

Keywords

retinal vein occlusion, rTPA

Brief summary

Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

Detailed description

Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations. Patient will be operated vitrectomy, and a branch retinal vein will be punctured by small needle and rTPA 200mcg/ml will be injected to the vein.

Interventions

PROCEDURERetinal endo vascular surgery

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* crvo less than 6 month * Visual Acuity less than 6/21 * No prior eye surgery except cataract.

Exclusion criteria

* Retinal/iris neovascularization

Design outcomes

Primary

Measure	Time frame
Visual acuity	—
Amount of macular edema.	—

Contacts

Primary ContactMichael Halpert, MD.

halpert@cc.huji.ac.il00972507874385

Backup ContactHadas Lemberg, PhD

Ihadas@hadassah.org.il0097226777572

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026